Advertisement

Topics

Roche poised for push into haemophilia market

08:20 EDT 3 Oct 2018 | pharmaphorum

Roche is aiming to shore up its place in the haemophilia drug market, with Hemlibra (emicizumab) on the brink of regulatory approval for expanded use. The US Food and Drug Administration (FDA) is this week expected to grant the Swiss pharma giant ...

Original Article: Roche poised for push into haemophilia market

NEXT ARTICLE

More From BioPortfolio on "Roche poised for push into haemophilia market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...